Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys

Pieter Vynckiera Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumCorrespondence[email protected]
View further author information

Johan De Sutterb Department of Cardiology, AZ Maria Middelares, Gent, Belgium;c Department of Internal Medicine, Ghent University, Ghent, BelgiumView further author information

Michel De Pauwc Department of Internal Medicine, Ghent University, Ghent, Belgium;d Department of Cardiology, Ghent University Hospital, Ghent, BelgiumView further author information

Hans Vandekerckhovee Department of Cardiology, AZ Sint Lucas, Ghent, BelgiumView further author information

Guy De Backera Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumView further author information

Pieter Vervaetd Department of Cardiology, Ghent University Hospital, Ghent, BelgiumView further author information

Nancy Deweerdte Department of Cardiology, AZ Sint Lucas, Ghent, BelgiumView further author information

Paul Dendalef Heart Centre Hasselt, Jessa Hospital and University of Hasselt, Hasselt, BelgiumView further author information

Alexandre Persug Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institute de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, BelgiumView further author information

Arne Janssenf Heart Centre Hasselt, Jessa Hospital and University of Hasselt, Hasselt, BelgiumView further author information

Patrick Chenug Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institute de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, BelgiumView further author information

Kornelia Kotsevah National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland;i Imperial College Healthcare NHS Trust, London, UKView further author information

Sofie Gevaertj Department of Internal Medicine and Pediatrics, Ghent University, Ghent, BelgiumView further author information

Dirk De Bacquera Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumView further author information

Delphine De Smedta Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumView further author information

& EUROASPIRE V Investigators Group show all

Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date